Progenics Pharmaceuticals (PGNX)
$3.59 0.26 (6.75%)
16:56 EDT PGNX Stock Quote Delayed 20 Minutes
Previous Close $3.59
Market Cap 264.65M
PE Ratio -5.20
Volume (Avg. Vol.) 718,900
Day's Range 3.48 - 3.80
52-Week Range 1.89 - 6.37
Dividend & Yield N/A (N/A)
PGNX Stock Predictions, Articles, and Progenics Pharmaceuticals News
- From InvestorPlace
- From the Web
Stock charts of NFLX, XRAY and UNM are dropping the most reliable technical hints as we head into a tricky trading environment.
In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers....
Small biotech stocks can pack a wallop. Here are five biotech stocks that have prospects bigger than their share prices.
The following stocks were moving the Manufacturing sector today.
This week, 27 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
The ratings of 32 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
3 Stocks to Watch on Wednesday: Progenics Pharmaceuticals, Inc. (PGNX), Intuitive Surgical, Inc. (ISRG) and Halliburton Company (HAL)
Progenics (PGNX) is popping on an FDA approval, Intuitive Surgical (ISRG) is up big on a Street-beating quarter and Halliburton (HAL) surprised to the upside.
Navellier RatingsPowered by Portfolio Grader